SurModics
SRDX
#6825
Rank
C$0.85 B
Marketcap
C$59.94
Share price
0.00%
Change (1 day)
6.71%
Change (1 year)
Categories

P/S ratio for SurModics (SRDX)

P/S ratio as of December 2025 (TTM): 5.09

According to SurModics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.52. At the end of 2025 the company had a P/S ratio of 3.41.

P/S ratio history for SurModics from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.41-24.11%
20244.4920.04%
20233.74-20.86%
20224.73-25.59%
20216.360.95%
20206.3012.34%
20195.61-23.83%
20187.3644.16%
20175.1110%
20164.6413.19%
20154.10-17.15%
20144.95-16.32%
20135.92-2.81%
20126.0931.23%
20114.6445.31%
20103.19-38.98%
20095.2359.85%
20083.27-73.52%
200712.451.46%
20068.16-22.98%
200510.6-4.32%
200411.126.23%
20038.77-44.35%
200215.8-38.09%
200125.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Nektar Therapeutics
NKTR
18.7 268.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
4.94-2.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
1.33-73.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
3.18-37.49%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
5.29 4.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.98-2.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
6.19 21.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
1.55-69.56%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
4.31-15.37%๐Ÿ‡บ๐Ÿ‡ธ USA